AstraZeneca PLC (AZN)

London


Symbol		Exchange		Currency
AZN	·	London	·	GBP	Real-time
3LAZ	·	London	·	GBP	Real-time
3SAZ	·	London	·	GBP	Real-time
AZNl	·	BATS Europe	·	GBP	Delayed
AZNs	·	BATS Europe	·	SEK	Delayed
AZN	·	NASDAQ	·	USD	Real-time
AZN	·	NYSE	·	USD	Real-time
AZNN	·	BIVA	·	MXN	Delayed
AZNN	·	Mexico	·	MXN	Delayed
AZN	·	Stockholm	·	SEK	Real-time
AZN	·	TradeGate	·	EUR	Delayed
AZN	·	Frankfurt	·	EUR	Delayed
AZNm	·	Buenos Aires	·	ARS	Delayed
A1ZN34	·	B3	·	BRL	Delayed

Currency in GBP

AZN Pro Research

14,560.0

-392.0(-2.62%)

Closed·11:35:59

Fair Value

Unlock Value

Day's Range

14,494.0

14,896.0

52 wk Range

9,651.0

15,730.0

AZN Income Statement

Assess the AstraZeneca income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the AZN net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

37,417

44,351

45,811

54,073

58,739

Total Revenues Growth

aa.aa

+40.58%

+18.53%

+3.29%

+18.03%

+8.63%

Cost Of Revenues

aa.aa

12,005

8,641

8,045

9,638

10,746

Gross Profit

aa.aa

25,412

35,710

37,766

44,435

47,993

Gross Profit Growth

aa.aa

+18.91%

+40.52%

+5.76%

+17.66%

+8.01%

Gross Profit Margin %

aa.aa

67.92%

80.52%

82.44%

82.18%

81.71%

Other Operating Expenses, Total

aa.aa

22,515

26,898

28,067

31,506

33,701

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+32.43%	+19.47%	+4.35%	+12.25%	+6.97%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	8,049	9,669	10,306	12,243	13,851
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	14,673	17,460	18,036	19,453	20,072
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-207	-231	-275	-190	-222

Operating Income

aa.aa

2,897

8,812

9,699

12,929

14,292

Operating Income Growth

aa.aa

-33.71%

+204.18%

+10.07%

+33.3%

+10.54%

EBIT Margin %

aa.aa

7.74%

19.87%

21.17%

23.91%

24.33%

Net Interest Expenses

aa.aa

-733

-836

-918

-1,058

-1,005

Net Interest Expenses Growth

aa.aa

-10.89%

-14.05%

-9.81%

-15.25%

+5.01%

Interest Expense, Total

aa.aa

-776

-917

-1,219

-1,403

-1,365

Interest And Investment Income

aa.aa

301

345

360

Other Non Operating Expenses, Total

aa.aa

-562

-391

-338

-204

-285

EBT, Excl. Unusual Items

aa.aa

1,602

7,585

8,443

11,667

13,002

Gain (Loss) On Sale Of Assets

aa.aa

509

216

292

154

Other Unusual Items, Total

aa.aa

-1,869

-1,099

-1,255

-1,882

-492

EBT, Incl. Unusual Items

aa.aa

-265

2,501

6,899

8,691

12,402

EBT, Incl. Unusual Items Growth

aa.aa

-106.77%

+1,043.77%

+175.85%

+25.97%

+42.7%

EBT, Incl. Unusual Items Margin

aa.aa

-0.71%

5.64%

15.06%

16.07%

21.11%

Income Tax Expense

aa.aa

-380

-792

938

1,650

2,169

Net Income to Company

aa.aa

115

3,293

5,961

7,041

10,233

Minority Interest

aa.aa

-3

-5

-6

-8

Net Income

aa.aa

112

3,288

5,955

7,035

10,225

Net Income Growth

aa.aa

-96.5%

+2,835.71%

+81.11%

+18.14%

+45.34%

Net Income Margin %

aa.aa

0.3%

7.41%

13%

13.01%

17.41%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

112

3,288

5,955

7,035

10,225

Basic EPS - Continuing Operations

aa.aa

0.08

2.12

3.84

4.54

6.6

Basic EPS - Continuing Operations Growth

aa.aa

-96.76%

+2,589.19%

+81%

+18.06%

+45.34%

Diluted EPS - Continuing Operations

aa.aa

0.08

2.11

3.81

4.5

6.54

Diluted EPS - Continuing Operations Growth

aa.aa

-96.76%

+2,571.43%

+80.57%

+18.11%

+45.33%

Basic Weighted Average Shares Outstanding

aa.aa

1,418

1,548

1,549

1,550

Diluted Weighted Average Shares Outstanding

aa.aa

1,427

1,560

1,562

1,563

1,562

Dividend Per Share

aa.aa

2.87

2.9

3.1

3.2

Dividend Per Share Growth

aa.aa

+2.5%

+1.05%

+6.9%

+3.23%

EBITDA

aa.aa

6,701

13,744

14,275

17,567

19,280

EBITDA Growth

aa.aa

-4.13%

+105.1%

+3.86%

+23.06%

+9.75%

EBITDA Margin %

aa.aa

17.91%

30.99%

31.16%

32.49%

32.82%

EBIT

aa.aa

2,897

8,812

9,699

12,929

14,292

* In Millions of USD (except for per share items)

FAQ

What was AstraZeneca’s revenue at year end?

At the end of the last reported fiscal year, AstraZeneca (AZN) recorded total revenue of 58,739.0 million USD.

How much revenue did AstraZeneca report in the most recent quarter?

In its most recent quarterly earnings report, AstraZeneca posted revenue of 15,503.0 million USD.

What was AstraZeneca’s net income for the year?

For the full year, AstraZeneca reported net income of 10,225.0 million USD.

How much net income did AstraZeneca post in the last quarter?

In the most recent quarter, AstraZeneca (AZN) posted net income of 2,326.0 million USD.

What was AstraZeneca’s gross profit for the year?

Gross profit for the year was reported at 47,993.0 million USD.

How much gross profit did AstraZeneca generate last quarter?

AstraZeneca recorded gross profit of 12,333.0 million USD in its latest quarterly report.

What was AstraZeneca’s annual operating income?

For the full year, AstraZeneca (AZN) reported operating income of 14,292.0 million USD.

What was AstraZeneca’s operating income last quarter?

Quarterly operating income was 3,347.0 million USD.

What was AstraZeneca’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 4,113.0 million USD.

What was the quarter-over-quarter change in EBITDA for AstraZeneca?

EBITDA changed by -21.1% million USD compared to the last quarter.

What is AstraZeneca’s most recent gross profit margin?

The latest reported gross profit margin for AstraZeneca (AZN) is 79.6% million USD.

What is AstraZeneca’s most recent net income margin?

Net income margin based on recent financials is 15.0% million USD.

What is AstraZeneca’s most recent EBIT margin?

AstraZeneca reported an EBIT margin of 21.6% million USD based on current figures.

How did AstraZeneca’s revenue change compared to the previous quarter?

Revenue changed by 2.1% million USD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for AstraZeneca?

In the latest quarter, gross profit changed by -0.5% million USD from the previous quarter.

S&P/TSX

33,970.06

-389.97

-1.13%

S&P/TSX 60

1,980.79

-17.25

-0.86%

US 30

49,362.50

-80.2

-0.16%

US 500

7,099.20

-10.0

-0.14%

S&P 500 VIX

19.52

+0.65

+3.44%

DAX

24,295.01

-122.79

-0.50%

Dollar Index

98.14

+0.233

+0.24%

Market Movers

Name	Last	Chg. %	Vol.
Canadian Natural	60.02	+1.67%	3.99M
RBC	243.56	-0.93%	3.63M
Toronto Dominion Bank	144.63	-0.54%	1.10M
Canadian Imperial Bank	149.38	-0.67%	987.99K
Shopify Inc	182.02	-1.36%	959.02K
Agnico Eagle Mines	280.88	-4.94%	602.17K
Celestica Inc.	554.39	+1.25%	363.81K

Name	Last	Chg. %	Vol.
Nirvana Life Sciences	0.04	+700.00%	11.33K
PeakBirch Logic	0.030	+500.00%	1.32K
New Leaf Ventures	0.05	+400.00%	666.82K
Irwin Naturals	0.30	+150.00%	3.24K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Rivalry	0.01	+100.00%	220.50K
Digicann Ventures	0.010	+100.00%	31.00K

Name	Last	Chg. %	Vol.
Metamaterial	0.25	-92.86%	0.00
Mayfair Acquisition	0.02	-80.00%	20.00K
New Frontier Ventures	0.030	-68.42%	13.00K
Moss Genomics	0.03	-57.14%	2.00K
Ultra Brands	0.02	-55.56%	60.00K
Molecule Holdings	0.005	-50.00%	20.11K
Blueberries Medical	0.0100	-50.00%	5.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Canadian Natural	60.02	+1.67%	3.99M
Hut 8	105.910	-1.76%	710.56K
TELUS	16.89	+0.30%	3.69M
Keel Infra	3.92	+0.26%	2.46M
Celestica Inc.	555.02	+1.37%	365.71K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaaaaaa	5.28	+61.25%	8.51
Aa Aaa Aaa Aaa	105.58	+48.58%	156.87
Aaaa Aaaaaaa Aa Aaa	43.61	+48.02%	64.55
Aaaaaaa	116.24	+44.34%	167.78
Aaaaaaaaaaaaa Aa A	6.51	+44.14%	9.38
Aaaaaa	22.96	+42.54%	32.73
Aaaaaa A Aaa Aaaaa A	261.65	+38.56%	362.54

Name	Last	Upside	Fair Value
Aaaaaaaaaaaaaa	5.28	+61.25%	8.51
Aa Aaa Aaa Aaa	105.58	+48.58%	156.87
Aaaa Aaaaaaa Aa Aaa	43.61	+48.02%	64.55
Aaaaaaa	116.24	+44.34%	167.78
Aaaaaaaaaaaaa Aa A	6.51	+44.14%	9.38
Aaaaaa	22.96	+42.54%	32.73
Aaaaaa A Aaa Aaaaa A	261.65	+38.56%	362.54

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

AstraZeneca PLC (AZN)

AZN Income Statement

FAQ

What was AstraZeneca’s revenue at year end?

How much revenue did AstraZeneca report in the most recent quarter?

What was AstraZeneca’s net income for the year?

How much net income did AstraZeneca post in the last quarter?

What was AstraZeneca’s gross profit for the year?

How much gross profit did AstraZeneca generate last quarter?

What was AstraZeneca’s annual operating income?

What was AstraZeneca’s operating income last quarter?

What was AstraZeneca’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for AstraZeneca?

What is AstraZeneca’s most recent gross profit margin?

What is AstraZeneca’s most recent net income margin?

What is AstraZeneca’s most recent EBIT margin?

How did AstraZeneca’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for AstraZeneca?

Trending Stocks